Manchester United Football Club, a professional soccer club based in Old Trafford, Greater Manchester, England, has sold 25% of its stake ownership to British billionaire Sir James Arthur Ratcliffe.
He is the chairman and chief executive officer of the INEOS chemicals group, which was established in 1998. He struck a deal with the team to acquire a minority stake in Manchester United.
Price of the Deal
It was agreed that Ratcliffe will buy a minority stake in Manchester United at $33 per share. With this price, the 25% share that he will acquire is equivalent to $6.3 billion. The involved parties confirmed the deal after a source initially shared it.
As per CNN Business, INEOS affirmed that its CEO is purchasing and said in a statement that Ratcliffe will have a quarter of Manchester Unite's Class B shares and up to 25% of its publicly available Class A shares. Ratcliffe will also give an additional $300 million to enable future investment into the team's historic stadium - the Old Trafford.
Ratcliffe Commits to Provide the Club's Needs to Win in Future Tournaments
The Glazer family owns the majority of Manchester United, and Class A shareholders will also get the same price of $33.00 per share. Then again, the stake acquisition deal still needs to be approved by the English Premier League.
"As a local boy and a lifelong supporter of the Club, I am very pleased that we have been able to agree on a deal with the Manchester United Board that delegates us management responsibility of the football operations of the Club," INEOS chief Sir Jim Ratcliffe said in a press release.
He added, "Whilst the commercial success of the Club has ensured there have always been available funds to win trophies at the highest level, this potential has not been fully unlocked in recent times. We will bring the global knowledge, expertise and talent from the wider INEOS Sport group to help drive further improvement at the Club."


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



